VIVI — TempraMed Technologies Balance Sheet
0.000.00%
- CA$54.87m
- CA$55.65m
- $1.84m
Annual balance sheet for TempraMed Technologies, fiscal year end - December 31st, millions except per share.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | |
| Standards: | — | IFRS | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | — | 0.053 | 0.021 | 0.953 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | — | 0.027 | 0.165 | 0.21 |
| Total Inventory | ||||
| Total Current Assets | — | 0.263 | 0.266 | 1.52 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | — | 0.241 | 0.201 | 0.324 |
| Other Long Term Assets | ||||
| Total Assets | — | 0.506 | 0.469 | 1.84 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | — | 1.55 | 3.52 | 3 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | — | 2.16 | 4.27 | 3.72 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | — | -1.65 | -3.8 | -1.88 |
| Total Liabilities & Shareholders' Equity | — | 0.506 | 0.469 | 1.84 |
| Total Common Shares Outstanding |